Walkersville, MD, United States of America

Robert J Kinders

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2017-2022.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 1


Location History:

  • Frederick, MD (US) (2017)
  • Walkersville, MD (US) (2020 - 2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Robert J Kinders

Introduction

Robert J Kinders is a notable inventor based in Walkersville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents to his name, Kinders has focused on creating innovative solutions for analytical, diagnostic, and therapeutic applications.

Latest Patents

Among his latest patents are the "Anti-CD133 monoclonal antibodies and related compositions and methods." These patents detail the advantageous properties of Anti-CD133 monoclonal antibodies, including products, compositions, and kits that comprise these antibodies. Additionally, the patents outline the processes for making these monoclonal antibodies and their applications in various fields.

Career Highlights

Robert J Kinders works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing the understanding and application of monoclonal antibodies in medical science.

Collaborations

Some of his notable coworkers include Thomas D Pfister and Tony Navas, who have collaborated with him on various projects related to his patents.

Conclusion

Robert J Kinders continues to be a significant figure in the field of biotechnology, with his innovative patents paving the way for advancements in medical applications. His contributions are vital to the ongoing research and development in this important area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…